KPV quick reference
What is KPV?
Three amino acids cut from the end of alpha-MSH, a natural hormone.
People use it for gut comfort and general inflammation.
No human trial; the evidence is mice and cells.
How KPV works
Gut and immune cells pull KPV in through the PepT1 transporter.
Inside cells, KPV lowered NF-kB and MAP kinase signals.
KPV and alpha-MSH slowed Staph and Candida growth in dishes.
What KPV is studied for
Oral KPV in drinking water eased two mouse colitis models.
KPV nanoparticles by mouth healed the colon lining in colitis mice.
Fewer tumours in KPV-treated mice; not shown in people.
Human gut and T cells made fewer inflammatory signals.
Slowed Staph and Candida growth in dishes.
KPV dosing protocol
| Item | What is known |
|---|---|
| Human dose | Not established |
| Studied in | Mice (in drinking water) and human cells in dishes |
| Human trials | None found |
Dalmasso 2008 (Gastroenterology). The abstract does not give the mouse dose. A search of ClinicalTrials.gov for KPV returned no studies.
Label and trial amounts come from the sources below. Community amounts are what people report; they have not been tested.
Mixing
Capsules are common. Oral and injected amounts are not interchangeable.
What the research found
No human results exist. In mice (two colitis models), by mouth in drinking water:
Dalmasso G et al. Gastroenterology 2008 (DSS and TNBS colitis in mice); Viennois E et al. Cell Mol Gastroenterol Hepatol 2016.
KPV community experience
What users report. Not tested in trials.
Positive reports
- Calmer gut Oral users report less gut irritation over several weeks.
- General calm Some injectors report fewer body-wide inflammatory symptoms.
- Pairs with BPC-157 Capsule combos are popular for gut goals.
Negative & mixed
- No clear change Some users notice nothing.
- Mild side effects Site irritation with injections; occasional stomach upset.
- Hard to credit Doses, forms and co-used products vary widely.
KPV stacking
Popular gut capsule pair. Not studied together.
Users say KPV softens GHK-Cu injection sting. Not studied together.
One part of a four-peptide blend. Not studied as a blend.
KPV side effects & safety
Common
- No human safety data.
- User reports: injection-site redness or soreness.
- User reports: mild nausea, stomach upset or headache.
- Oral product quality and strength vary.
Less common
- Long-term immune and metabolic effects are unknown.
- Injectable vials can carry contamination risk.
- Mouse tumour results do not show cancer safety in people.
Precautions
- Avoid in pregnancy or breastfeeding; no data.
- Known allergy to KPV or vial ingredients.
- Active bowel disease or cancer needs standard medical care.
- Do not assume capsule and injected amounts match.
Our verdict on KPV
Neat mouse-gut story with a clear mechanism. No human trials, so benefits are unproven.
KPV FAQ
Does KPV work by mouth?
In mice, yes, through the PepT1 gut transporter. Human effects are untested.
Is KPV the same as alpha-MSH?
No. KPV is only the last three amino acids of it.
Is there a human KPV dose?
No. No human trial exists.
Sources
- Dalmasso G et al. Gastroenterology 2008, PMID 18061177
- Viennois E et al. Cell Mol Gastroenterol Hepatol 2016, PMID 27458604
- ClinicalTrials.gov search for KPV: no studies
- Drugs@FDA / openFDA search: no KPV product
- Kannengiesser K et al. Inflamm Bowel Dis 2008 (KPV in two mouse colitis models), PMID 18092346
- Xiao B et al. Mol Ther 2017 (oral KPV nanoparticles, mouse colitis), PMID 28143741
- Cutuli M et al. J Leukoc Biol 2000 (alpha-MSH peptides vs Staph and Candida), PMID 10670585